• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Torax Medical Inc.

J&J’s Ethicon touts economic study of magnetic Torax GERD device

April 9, 2019 By Brad Perriello

Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon touted a study showing that the Linx device it acquired two years ago was cheaper than laparoscopic Nissen fundoplication in treating gastrointestinal reflux disease. Shoreview, Minn.-based Torax Medical makes the Linx device, an implant of interlinked titanium beads with magnetic cores designed to augment the esophageal sphincter to prevent […]

Filed Under: Clinical Trials, Weight loss Tagged With: Ethicon, Johnson and Johnson, Torax Medical Inc.

Torax Medical touts preliminary results from Linx GERD study

May 24, 2017 By Fink Densford

Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon‘s Torax Medical business today released results from the Caliber trial of its Linx system for treating gastro-esophageal reflux disease, touting quality of life improvements and reduction in reflux levels. The Linx system is an implant composed of interlinked titanium beads with magnetic cores that augments the esophageal sphincter’s barrier […]

Filed Under: Clinical Trials, Otolaryngology/Ear, Nose & Throat (ENT) Tagged With: Ethicon, Johnson and Johnson, Torax Medical Inc.

Ethicon closes Torax Medical buy

March 23, 2017 By Fink Densford

Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said today it closed its acquisition of Torax Medical, and its Linx acid reflux treatment portfolio, for an undisclosed amount. The Linx system from Shoreview, Minn.-based Torax is an implant composed of interlinked titanium beads with magnetic cores that augments the esophageal sphincter’s barrier function to prevent reflux in patients […]

Filed Under: Mergers & Acquisitions, Otolaryngology/Ear, Nose & Throat (ENT) Tagged With: Ethicon, Johnson and Johnson, Torax Medical Inc.

J&J’s Ethicon to buy Torax Medical

February 17, 2017 By Brad Perriello

Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon agreed to buy Torax Medical and its Linx acid reflux treatment for an undisclosed amount. J&J, which got in on a $25 million funding round for Torax last year, said the deal is “consistent with Ethicon’s strategy of advancing innovation and investing in areas of unmet medical needs such as esophageal […]

Filed Under: Mergers & Acquisitions, Otolaryngology/Ear, Nose & Throat (ENT), Wall Street Beat Tagged With: Ethicon, Johnson and Johnson, Torax Medical Inc.

Firms in Minnesota’s Medical Alley raised $117m in Q3

October 13, 2016 By Fink Densford

Firms in Minnesota’s Medical Alley raised $117 million during the 3rd quarter, bringing their total year-to-date funding to $335.8 million, the trade group reported today. Medical Alley, which rebranded from LifeScience Alley in January, reported that 77 companies from the region completed funding rounds in 2016, matching 2015’s numbers between the 1st and 3rd quarters. “Medical Alley continues to […]

Filed Under: Funding Roundup, Wall Street Beat Tagged With: Cogentix Medical, CVRx Inc., Medical Alley, Osprey Medical, rotationmedical, Torax Medical Inc.

J&J gets in on $25m Torax Medical Series E

August 11, 2016 By Fink Densford

Torax Medical recently updated on the $25 million Series E round it 1st announced in an SEC filing in late July, saying the round was led by Johnson & Johnson Innovation. Funds from the round are slated to commercially scale its platform of products used to treat chronic diseased related to weak sphincter muscles, including […]

Filed Under: Business/Financial News Tagged With: Torax Medical Inc.

Torax Medical raises $25m

July 25, 2016 By Fink Densford

Torax Medical raised $25 million in a new round of equity financing, according to an SEC filing posted today. Torax develops the Fenix magnetic continence restoration system, which is made up of a series of magnetic titanium beads that are implanted in the anal sphincter to minimize the involuntary opening of the anal canal. The system […]

Filed Under: Business/Financial News Tagged With: Torax Medical Inc.

Torax touts 1st US use of Fenix incontinence system

April 13, 2016 By Fink Densford

Torax Medical said today that the 1st U.S. implantation of its Fenix magnetic continence restoration system was performed late last week. The Fenix system is made up of a series of magnetic titanium beads that are implanted in the anal sphincter to minimize the involuntary opening of the anal canal. The system comes with a tool to size the […]

Filed Under: Blog Tagged With: Torax Medical Inc.

Torax wins FDA HDE clearance for Fenix incontinence system

January 5, 2016 By Fink Densford

Torax Medical said today its Fenix continence restoration system won FDA Humanitarian Device Exemption approval for treating fecal incontinence. The Fenix system is made up of a series of magnetic titanium beads that are implanted in the anal sphincter to minimize the involuntary opening of the anal canal. The system comes with a tool to size the […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Torax Medical Inc.

Torax wins FDA nod for Fenix incontinence treatment system

December 18, 2015 By Fink Densford

Torax Medical said the FDA granted premarket approval for its Fenix continence restoration system designed to treat fecal incontinence in patients who are not candidates for, or have failed with other options to treat the issue. The Fenix system is made up of a series of magnetic titanium beads that are implanted in the anal sphincter […]

Filed Under: Food & Drug Administration (FDA), Implants, Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: Torax Medical Inc.

Torax touts Linx GERD study

July 27, 2015 By Fink Densford

Torax Medical said today that data from a new study of its Linx reflux management system reported the treatment to be as effective as the standard-of-care Laproscopic Nissen Fundoplication treatment. The Linx system is an implant composed of interlinked titanium beads with magnetic cores that augments the esophageal sphincter’s barrier function to prevent reflux in patients with gastro-esophageal […]

Filed Under: Clinical Trials, Implants, Surgical Tagged With: Torax Medical Inc.

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS